Wai Yuen Tong Medicine Holdings Limited provided consolidated earnings guidance for the six months ended 30 September 2023. The group is expected to record a turnaround from a loss attributable to owners of the parent for the six months ended 30 September 2022 of approximately HKD 53.4 million to a profit attributable to owners of the parent of not more than approximately HKD 20.0 million for the six months ended 30 September 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.23 HKD | 0.00% | 0.00% | -42.50% |
1st Jan change | Capi. | |
---|---|---|
-42.50% | 33.13M | |
+39.33% | 6.11B | |
-18.38% | 4.35B | |
-9.17% | 3.19B | |
+3.98% | 3.15B | |
-3.41% | 2.51B | |
+48.74% | 1.98B | |
-4.82% | 1.74B | |
-1.24% | 1.63B | |
-8.96% | 1.6B |
- Stock Market
- Equities
- 897 Stock
- News Wai Yuen Tong Medicine Holdings Limited
- Wai Yuen Tong Medicine Holdings Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 September 2023